Gapping up
In reaction to earnings/guidance:
- PLAY +5.5%, AVO +1.2%
Other news:
- NOVN +39.4% (reports Phase 3 Trial of SB206 met primary endpoint)
- PGEN +27.6% (announces "positive" top-line results from Phase 1b/2a study of AG019)
- AMEH +10.8% (to be added to S&P SmallCap 600)
- ATC +7.6% (MKS Instruments (MKSI) eyeing Atotech acquisition, according to Reuters)
- EQ +7.4% (announces "positive" topline data from the Phase 1b EQUATE study in first-line acute graft-versus-host-disease)
- RFP +7.2% (declares special dividend of $1/sh; also announces $50 mln in lumber investments)
- ADMP +6.9% (reports clinical trial start-up activities are underway for examining the effects of Tempol in the treatment of COVID-19)
- MBIO +6.3% (updates interim data from the ongoing Phase 1/2 clinical trial investigating the safety and efficacy of MB-106 CD20-targeted, autologous CAR T cell therapy)
- CNTY +5.2% (reopening its four casinos in Alberta, Canada)
- TYME +5% (completes strategic review, announces OASIS breast trial with Georgetown, reports earnings)
- SRRK +4.9% (presents TOPAZ Phase 2 data showing the transformative potential of apitegromab in patients with Type 2 and 3 spinal muscular atrophy)
- AUTL +4.2% (presents new data on obe-cel in r/r indolent B Cell lymphomas and gives an update of obe-cel in r/r Adult ALL)
- VCTR +3.8% (reports May AUM)
- LSCC +3.8% (Infineon is using LSCC FPGA as part of its Pictor design)
- CVI +3.2% (finalizes special dividend payment)
- EDIT +2.1% (reports preclinical data supporting the initiation of the EDIT-301 Phase 1/2 RUBY Clinical Trial for the treatment of sickle cell disease)
- ABCL +2% (stock offering)
- YAC +1.4% (SIGNA Sports United to go public on NYSE through combination with Yucaipa Acquisition Corporation)
- IMRA +1.4% (Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association)
- BSN +1.3% (announces combination agreement with Vertical Aerospace; also Avolon confirms eVTOL aircraft order with Vertical Aerospace; also AAL confirms investment in Vertical Aerospace and aircraft pre-order agreement)
- RWT +1.1% (increases dividend)
Analyst comments:
- ERJ +4% (upgraded to Buy from Neutral at BofA Securities)
- CELH +3.2% (upgraded to Outperform from Neutral at Credit Suisse)
- BIIB +1% (upgraded to Outperform from Mkt Perform at Bernstein)